Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Publication year range
1.
Acta Clin Belg ; 69(3): 208-9, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24820920

ABSTRACT

Reversible lesions of the splenium of the corpus callosum constitute a clinicoradiological syndrome that has been associated to various medical conditions. We report the case of a 47-year-old man who presented with encephalopathy associated to auto-immune thyroid disease in which a reversible splenial lesion was isolated. Although encephalopathy associated to auto-immune thyroid disease is characterized by variable radiological findings, it has only been once associated with a reversible splenial lesion.


Subject(s)
Brain Diseases/diagnosis , Brain Diseases/etiology , Corpus Callosum , Hashimoto Disease/diagnosis , Hashimoto Disease/etiology , Brain Diseases/therapy , Encephalitis , Hashimoto Disease/therapy , Humans , Male , Middle Aged
4.
Acta Clin Belg ; 55(3): 176-81, 2000.
Article in English | MEDLINE | ID: mdl-10981327

ABSTRACT

Heparin-induced thrombocytopaenia is a dreaded, although infrequent, complication of heparin therapy. We report two cases of heparin-induced thrombocytopaenia (HIT) type II occurring in a patient treated with standard (unfractionated) heparin and in another patient given a low-weight molecular heparin. The clinical course of the first patient illustrates the potentially severe thrombotic complications of HIT. Both cases were treated successfully by danaparoid sodium. Clues to the diagnosis and treatment are briefly discussed.


Subject(s)
Anticoagulants/adverse effects , Antithrombin III/therapeutic use , Chondroitin Sulfates/therapeutic use , Dermatan Sulfate/therapeutic use , Heparin/adverse effects , Heparinoids/therapeutic use , Heparitin Sulfate/therapeutic use , Thrombocytopenia/chemically induced , Thrombosis/chemically induced , Venous Thrombosis/chemically induced , Drug Combinations , Female , Heparin, Low-Molecular-Weight/adverse effects , Humans , Male , Middle Aged , Thrombocytopenia/drug therapy , Thrombosis/drug therapy , Venous Thrombosis/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...